Diagnostic and therapeutic challenges

Retina. 2009 Feb;29(2):275-9. doi: 10.1097/IAE.0b013e3181893787.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acetazolamide / therapeutic use
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Carbonic Anhydrase Inhibitors / therapeutic use
  • Diabetes Mellitus, Type 2 / complications
  • Diabetic Retinopathy / complications
  • Diabetic Retinopathy / drug therapy*
  • Diabetic Retinopathy / physiopathology
  • Fluorescein Angiography
  • Glucocorticoids / therapeutic use
  • Humans
  • Laser Coagulation
  • Macular Edema / drug therapy*
  • Macular Edema / etiology
  • Macular Edema / physiopathology
  • Male
  • Middle Aged
  • Recurrence
  • Retina / drug effects*
  • Retina / pathology
  • Sulfonamides / therapeutic use
  • Thiazines / therapeutic use
  • Tomography, Optical Coherence
  • Triamcinolone Acetonide / therapeutic use
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity / physiology

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Carbonic Anhydrase Inhibitors
  • Glucocorticoids
  • Sulfonamides
  • Thiazines
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • brinzolamide
  • Triamcinolone Acetonide
  • Acetazolamide